357 related articles for article (PubMed ID: 18370241)
1. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
4. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
Bernig T; Chanock SJ
Expert Rev Mol Diagn; 2006 May; 6(3):319-31. PubMed ID: 16706736
[TBL] [Abstract][Full Text] [Related]
5. [Value and applications of pharmacogenetics in oncology and hematology].
Albin N; Massade L; Gouyette A
Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics in gastrointestinal disorders.
Camilleri M; Saito YA
Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
[TBL] [Abstract][Full Text] [Related]
8. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy.
Dawood S
Cancer Invest; 2009 Oct; 27(8):809-15. PubMed ID: 19731103
[No Abstract] [Full Text] [Related]
10. Pharmacogenomics of cancer chemotherapy-induced toxicity.
Miller CR; McLeod HL
J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing in cancer therapeutics.
Ezzeldin HH; Diasio RB
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
[No Abstract] [Full Text] [Related]
12. [Use of molecular genetic analysis in selecting antitumor therapy].
Imianitov EN; Moiseenko VM
Vopr Onkol; 2008; 54(2):121-32. PubMed ID: 18522159
[No Abstract] [Full Text] [Related]
13. Genetic profiling can predict chemotherapy side effects and treatment response.
Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
[No Abstract] [Full Text] [Related]
14. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
15. Individualized drug therapy.
Daly AK
Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
[TBL] [Abstract][Full Text] [Related]
16. Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.
Auman JT; McLeod HL
Drug Metab Rev; 2008; 40(2):303-15. PubMed ID: 18464047
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetics in fluoropyrimidine chemotherapy].
Ichikawa W; Sasaki Y
Gan To Kagaku Ryoho; 2008 Feb; 35(2):178-81. PubMed ID: 18281752
[TBL] [Abstract][Full Text] [Related]
18. Cancer pharmacogenetics: polymorphisms, pathways and beyond.
Ulrich CM; Robien K; McLeod HL
Nat Rev Cancer; 2003 Dec; 3(12):912-20. PubMed ID: 14740638
[No Abstract] [Full Text] [Related]
19. Recent advances in the pharmacogenetics of cancer chemotherapy.
Watters JW; McLeod HL
Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of cytotoxic drugs.
Daly AK; Hall AG
Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
